ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

BOLT Bolt Biotherapeutics Inc

1.10
0.00 (0.00%)
07 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Bolt Biotherapeutics Inc BOLT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 1.10 09:00:00
개장가 저가 고가 종가 전일 종가
1.10 1.08 1.11 1.10 1.10
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
22/03/202405:05GLOBEBolt Biotherapeutics Reports Fourth Quarter and Full-Year..
07/03/202403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202403:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202421:00GLOBEBolt Biotherapeutics to Present at the TD Cowen 44th Annual..
13/02/202411:41EDGAR2Form SC 13D/A - General statement of acquisition of..
07/02/202403:09EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
21/12/202321:30GLOBEPacira Appoints Frank D. Lee as Chief Executive Officer
14/12/202303:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202321:00GLOBEBolt Biotherapeutics Enrolls First Patient in Phase 2..
10/11/202306:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:08EDGAR2Form 8-K - Current report
10/11/202306:05GLOBEBolt Biotherapeutics Reports Third Quarter 2023 Financial..
07/11/202321:00GLOBEBolt Biotherapeutics to Present at Stifel 2023 Healthcare..
23/10/202323:30GLOBEBolt Biotherapeutics Presents Updated Clinical Data from..
18/10/202320:00GLOBEBolt Biotherapeutics to Present Data at the Society for..
17/10/202320:00GLOBEBolt Biotherapeutics Announces First Patient Dosed in Phase..
16/10/202320:00GLOBEBolt Biotherapeutics to Present New Clinical Data from..
28/09/202320:00GLOBEBolt Biotherapeutics Receives Orphan Drug Designation for..
12/09/202321:05GLOBEBolt Biotherapeutics Announces Issuance of U.S. Patent..
06/09/202305:15GLOBEBolt Biotherapeutics to Participate in September Investor..
08/08/202305:10GLOBEBolt Biotherapeutics Reports Second Quarter 2023 Financial..
08/08/202305:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202305:06EDGAR2Form 8-K - Current report
03/08/202320:30GLOBEBolt Biotherapeutics Initiates Phase 2 Clinical Studies of..
01/08/202306:27GLOBEBolt Biotherapeutics to Present at BTIG Virtual..
30/05/202321:00PRNUSBioLight announces a joint cooperation agreement with..
26/05/202306:05GLOBEBolt Biotherapeutics Highlights Comprehensive Clinical Data..
12/05/202305:05GLOBEBolt Biotherapeutics Reports First Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock